RGS7 (regulator of G protein signaling) Inhibitors
RGS7 inhibitors are a class of chemical compounds that specifically target and inhibit the function of regulator of G protein signaling 7 (RGS7), a member of the RGS protein family involved in the modulation of G protein-coupled receptor (GPCR) signaling pathways. RGS7 acts as a GTPase-activating protein (GAP), accelerating the hydrolysis of GTP to GDP on the α subunit of G proteins, thereby terminating the signal transduction initiated by GPCR activation. By shortening the active state of G proteins, RGS7 plays a crucial role in regulating the intensity and duration of cellular responses to various extracellular stimuli, such as hormones, neurotransmitters, and sensory signals. Inhibitors of RGS7 disrupt this regulatory function, allowing G proteins to remain active for longer periods, which can alter downstream signaling events within the cell.
Inhibiting RGS7 provides a valuable tool for studying GPCR signaling dynamics and the mechanisms that control signal termination in cells. By blocking RGS7 activity, researchers can observe the effects of prolonged G protein activation, revealing insights into how cells respond to sustained signals and the role of RGS proteins in maintaining signal fidelity. Additionally, RGS7 is involved in specific cellular processes, such as neuronal signaling and sensory perception, making its inhibition particularly useful for understanding how G protein regulation impacts these specialized functions. The study of RGS7 inhibitors allows for a deeper exploration of the fine-tuned balance between signal activation and deactivation within GPCR pathways, highlighting the importance of precise regulation in maintaining cellular communication and overall physiological function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may downregulate RGS7 by increasing histone acetylation, which could change the chromatin structure around the RGS7 gene, leading to decreased transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This chemical could reduce RGS7 expression by inhibiting DNA methyltransferase, which might result in hypomethylation of the gene's promoter area, facilitating transcriptional repression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 may decrease RGS7 expression by demethylating CpG islands within the RGS7 gene promoter, potentially reducing the binding of methyl-CpG-binding domain proteins that enhance transcription. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to DNA in the RGS7 promoter region, Mithramycin A could obstruct the attachment of transcriptional machinery, leading to a decline in RGS7 mRNA synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine could inhibit RGS7 expression by intercalating into DNA and RNA, disrupting the transcriptional process specifically at the RGS7 gene locus. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may suppress RGS7 expression by intercalating into DNA and obstructing the elongation phase of RNA synthesis by RNA polymerase, particularly impacting RGS7. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 could downregulate RGS7 by inhibiting the BET family of bromodomain proteins, possibly leading to the repression of transcription factors critical for RGS7 mRNA production. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
By inhibiting mTOR, Rapamycin (Sirolimus) could lead to the downregulation of several genes, including RGS7, by reducing the overall rate of protein synthesis and cell proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 may decrease RGS7 gene expression by inhibiting the PI3K/AKT pathway, resulting in decreased activation of transcription factors that promote RGS7 transcription. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
Wiskostatin could reduce RGS7 expression by inhibiting glucose transporters, leading to cellular energy deficits and a resultant decrease in energy-dependent transcriptional activity. | ||||||